Alnylam Pharmaceuticals Inc. (ALNY) Dividend History
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
Last update 12/14/2019
Dividend Yield Summary
|Date||Amount Per Share||Note|